Beckman Coulter brings a multicentre spectral AML MRD harmonisation initiative to ICCS 2026
Summary
Beckman Coulter's ICCS 2026 program scheduled a workshop for 4 October on an international initiative evaluating spectral flow cytometry for AML MRD research. Its stated aims include workflow harmonisation, standardized acquisition and analysis, and multicentre implementation. The program listing does not establish completed presentation or multicentre performance.
The evidence
Beckman Coulter lists a 4 October ICCS workshop titled Broadening the Spectrum: An International Collaboration in MRD Detection, with Wolfgang Kern and Alan Dunlop. The company says the initiative involves experts from Europe, North America and South America and focuses on harmonizing workflows, standardizing acquisition and analysis, and establishing multicentre best practices.
CFCM explainer
Common workflow → standardized acquisition → common analysis → multicentre reproducibility.
Source/credit: CFCM conceptual explainer based on the primary ICCS workshop description. Alt text: standardisation chain from workflow to multicentre reproducibility.
Interpretation and limitations
The source specifies a scheduled workshop date, not a verified completed presentation. It does not provide sample size, participating-site list, panel specification, acceptance criteria or performance results. CFCM records the initiative as listed in the program, not as successful harmonisation.
What this means for laboratories
Multicentre spectral AML MRD harmonisation addresses a central transferability problem: high dimensionality is only clinically useful if staining, acquisition, unmixing and interpretation can be reproduced across sites. CFCM publishes the initiative as WATCH, not as proof that harmonisation has already succeeded. The next evidence threshold is quantitative inter-site performance.
Source Date
Event date
October 4, 2026
Commercial Regulatory Status
Research/clinical-research initiative; no new product authorization or diagnostic approval established by the event page.
Primary source
Read the source →An announcement is not proof of availability or authorisation. Interpret status within the stated jurisdiction and evidence boundary.
Editor and independence disclosure →CFCM WEEKLY · EVERY SUNDAY
The science behind the signal, in your inbox.
Get evidence-led clinical flow cytometry news, original conference posters, figures from published papers, practical learning pills, an advanced quiz and the story of one CD marker each week. Free. No spam.
Get CFCM Weekly →Complete the form and confirm the email we send you. Unsubscribe any time. Privacy policy.